Large-scale testing (Phase 3)Study completedNCT00226707
What this trial is testing
Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis
Who this might be right for
Chronic Hand Dermatitis
Novartis 652